Lipid Panel, C-Peptide, Glucose tolerance (OGTT)
- $193.91
- $69.95
- Save: 63.93%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: C-Terminal Insulin, Connecting peptide insulin, CPeptide, Insulin C-peptide, Proinsulin C-peptide
C-Peptide
Also known as: Glucose Tolerance Test 2 Specimens 75g
2 Hour Specimen
Fasting Specimen
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
LDL/HDL Ratio
Non HDL Cholesterol
Triglycerides
The Lipid Panel, C-Peptide, Glucose tolerance (OGTT) panel contains 3 tests with 10 biomarkers .
Lipid Panel, C-Peptide, Glucose tolerance test (OGTT)
- C-Peptide
- Glucose Tolerance Test, 2 Specimens (75g) - Includes fasting Glucose
- Lipid Panel with Ratios
Glucose Tolerance Test, 2 Specimens (75g) - Clinical Significance
- This test is used for the routine diagnosis of diabetes in children and the non-pregnant adult. For pregnant females see test "Glucose Tolerance Test, Gestational, 4 Specimens (100 g)". For appropriate interpretation of this test, the patient must fast overnight and ingest a 75 g load of glucose, immediately after, a fasting specimen is obtained. For children, the glucose load is 1.75 g/Kg of ideal body weight, up to 75 g glucose. The diagnosis of diabetes is made if the fasting glucose is ≥126 mg/dL or if the 2-hour specimen is ≥200 mg/dL.
- Reference Range(s) American Diabetes Association, Diagnostic Criteria for Diabetes Mellitus
Lipid Panel with Ratios
- Total Cholesterol, HDL Cholesterol, Triglycerides, LDL-Cholesterol (calculated), Cholesterol/HDL Ratio (calculated), LDL/HDL Ratio (calculated), Non-HDL Cholesterol (calculated)
C-Peptide - Clinical Significance
- C-Peptide is useful in the evaluation of pancreatic beta cell function (e.g., helping distinguish type 1 from type 2 diabetes mellitus, or monitoring patients who have received islet cell or pancreatic transplants) and for determining the source of insulin in patients with hyperinsulinemic hypoglycemia (e.g., distinguishing insulin-secreting tumors from exogenous insulin administration). It is also sometimes measured as an additional means (more resistant to hemolysis than is insulin itself) for evaluating glucose tolerance tests.